Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol

Jordana B. Cohen, Thomas C. Hanff, Vicente Corrales-Medina, Preethi William, Nicolas Renna, Nelson R. Rosado-Santander, Juan E. Rodriguez-Mori, Jonas Spaak, Jaime Andrade-Villanueva, Tara I. Chang, Alejandro Barbagelata, Carlos E. Alfonso, Eduardo Bernales-Salas, Johanna Coacalla, Carlos Augusto Castro-Callirgos, Karen E. Tupayachi-Venero, Carola Medina, Renzo Valdivia, Mirko Villavicencio, Charles R. VasquezMichael O. Harhay, Jesse Chittams, Tiffany Sharkoski, James Brian Byrd, Daniel L. Edmonston, Nancy Sweitzer, Julio A. Chirinos

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol'. Together they form a unique fingerprint.

Medicine & Life Sciences